Cargando…
Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression
For the recombinant expression of toxin-based drugs, a crucial step lies not only in the choice of the production host(s) but also in the accurate design of the protein chimera. These issues are particularly important since such products may be toxic to the expressing host itself. To avoid or limit...
Autores principales: | Zuppone, Stefania, Fabbrini, Maria Serena, Vago, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630761/ https://www.ncbi.nlm.nih.gov/pubmed/31108917 http://dx.doi.org/10.3390/biomedicines7020038 |
Ejemplares similares
-
From Immunotoxins to Suicide Toxin Delivery Approaches: Is There a Clinical Opportunity?
por: Ardini, Matteo, et al.
Publicado: (2022) -
Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions)
por: Fabbrini, Maria Serena, et al.
Publicado: (2017) -
The cell type dependent sorting of CD9- and CD81 to extracellular vesicles can be exploited to convey tumor sensitive cargo to target cells
por: Zuppone, Stefania, et al.
Publicado: (2022) -
Clinical targeting recombinant immunotoxins for cancer therapy
por: Li, Meng, et al.
Publicado: (2017) -
Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
por: Hagerty, Brendan L., et al.
Publicado: (2020)